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ERRATUM Open Access
Erratum to: JMJD6 is a driver of cellular
proliferation and motility and a marker of
poor prognosis in breast cancer
Yi Fang Lee1, Lance David Miller2, Xiu Bin Chan1, Michael A. Black6, Brendan Pang3, Chee Wee Ong3,
Manuel Salto-Tellez4,5, Edison T. Liu7 and Kartiki V. Desai8*
Erratum
Main text: After the publication of this work [1] an
error was noticed in Fig. 8. In the SMAD2P465/467
panel, the images for MCF-7 and MDA MB 231 cells
were accidentally duplicated. The corrected figure is
shown below. We apologize for this error, which does
not affect the findings or conclusions of the article.
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Fig. 8 JMJD6 expression affects SMAD phosphorylation. Immunoblots
show that the level of total SMAD2/3, phosphorylated SMAD2 and
phosphorylated SMAD3 are decreased in MCF-7 J1-OE clones, and
increased in JMJD6 siRNA-mediated knock-down in MCF-7 and MDA-
MB231. The numbers next to the SMAD2P/3P denote the expected
sites of phosphorylation detected by the antibodies. N.S. denotes
non-specific bands from the blots which indicate equal loading of the
protein lysates
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